Published in Brain Res on October 18, 2010
ELITE: Early Versus Late Intervention Trial With Estradiol | NCT00114517
Kronos Early Estrogen Prevention Study (KEEPS) | NCT00154180
The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat Rev Neurosci (2012) 2.76
Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology (2013) 1.76
Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. Clin Epidemiol (2014) 1.56
A lack of ovarian function increases neuroinflammation in aged mice. Endocrinology (2012) 1.53
C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-alpha and the critical period hypothesis of estrogen neuroprotection. Proc Natl Acad Sci U S A (2011) 1.31
Estrogen and the prefrontal cortex: towards a new understanding of estrogen's effects on executive functions in the menopause transition. Hum Brain Mapp (2012) 1.12
Dementia prevention: current epidemiological evidence and future perspective. Alzheimers Res Ther (2012) 1.07
Interactive effects of age and estrogen on cortical neurons: implications for cognitive aging. Neuroscience (2011) 1.06
Estrogen neuroprotection and the critical period hypothesis. Front Neuroendocrinol (2011) 1.03
Oophorectomy, estrogen, and dementia: a 2014 update. Mol Cell Endocrinol (2014) 1.02
Hysterectomy, oophorectomy, estrogen, and the risk of dementia. Neurodegener Dis (2012) 1.01
Sex and gender differences in the causes of dementia: a narrative review. Maturitas (2014) 1.00
The potential association between postmenopausal hormone use and primary open-angle glaucoma. JAMA Ophthalmol (2014) 0.99
Minireview: translational animal models of human menopause: challenges and emerging opportunities. Endocrinology (2012) 0.94
Roles for oestrogen receptor β in adult brain function. J Neuroendocrinol (2012) 0.94
Long-term health consequences of premature or early menopause and considerations for management. Climacteric (2015) 0.93
Continuous estrone treatment impairs spatial memory and does not impact number of basal forebrain cholinergic neurons in the surgically menopausal middle-aged rat. Horm Behav (2012) 0.92
Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury. Prog Neurobiol (2016) 0.90
Premature menopause and risk of neurological disease: basic mechanisms and clinical implications. Mol Cell Endocrinol (2014) 0.89
Accelerated ovarian failure: a novel, chemically induced animal model of menopause. Brain Res (2011) 0.89
Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort. Mult Scler (2015) 0.89
A dominant negative ERβ splice variant determines the effectiveness of early or late estrogen therapy after ovariectomy in rats. PLoS One (2012) 0.88
Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD. Bone Marrow Transplant (2014) 0.86
Estrogen regulation of Dkk1 and Wnt/β-Catenin signaling in neurodegenerative disease. Brain Res (2012) 0.84
Causes and consequences of age-related steroid hormone changes: insights gained from nonhuman primates. J Neuroendocrinol (2013) 0.84
Oestrogen signalling and neuroprotection in cerebral ischaemia. J Neuroendocrinol (2012) 0.83
Risk of glaucoma after early bilateral oophorectomy. Menopause (2014) 0.83
Hypersensitivity of the hippocampal CA3 region to stress-induced neurodegeneration and amyloidogenesis in a rat model of surgical menopause. Brain (2013) 0.83
Rapid estradiol modulation of neuronal connectivity and its implications for disease. Front Endocrinol (Lausanne) (2011) 0.83
Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause. Biol Sex Differ (2013) 0.83
Female reproductive factors, menopausal hormone use, and Parkinson's disease. Mov Disord (2013) 0.82
The prodrug DHED selectively delivers 17β-estradiol to the brain for treating estrogen-responsive disorders. Sci Transl Med (2015) 0.82
Prescribing menopausal hormone therapy: an evidence-based approach. Int J Womens Health (2014) 0.81
Factors influencing the cognitive and neural effects of hormone treatment during aging in a rodent model. Brain Res (2013) 0.80
Menopausal hot flashes and white matter hyperintensities. Menopause (2016) 0.80
Re-Opening the Critical Window for Estrogen Therapy. J Neurosci (2015) 0.79
Long-term estrogen deprivation leads to elevation of Dickkopf-1 and dysregulation of Wnt/β-Catenin signaling in hippocampal CA1 neurons. Steroids (2012) 0.79
Hormone therapy use and physical quality of life in postmenopausal women with multiple sclerosis. Neurology (2016) 0.78
Menopause, obesity and inflammation: interactive risk factors for Alzheimer's disease. Front Aging Neurosci (2015) 0.78
Menopause in multiple sclerosis: therapeutic considerations. J Neurol (2013) 0.77
Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition. J Alzheimers Dis (2016) 0.77
Congress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular disease. J Womens Health (Larchmt) (2014) 0.77
Aging and Loss of Circulating 17β-Estradiol Alters the Alternative Splicing of ERβ in the Female Rat Brain. Endocrinology (2015) 0.76
Sex and the development of Alzheimer's disease. J Neurosci Res (2017) 0.76
A mechanism emerges for the critical period hypothesis for estrogen treatment. Proc Natl Acad Sci U S A (2011) 0.76
Trajectories and phenotypes with estrogen exposures across the lifespan: What does Goldilocks have to do with it? Horm Behav (2015) 0.76
Differential Effects of E2 on MAPK Activity in the Brain and Heart of Aged Female Rats. PLoS One (2016) 0.75
Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease. Int J Mol Sci (2016) 0.75
Comparison of the Antidepressant-Like Effects of Estradiol and That of Selective Serotonin Reuptake Inhibitors in Middle-Aged Ovariectomized Rats. Front Aging Neurosci (2016) 0.75
Is Estrogen a Therapeutic Target for Glaucoma? Semin Ophthalmol (2016) 0.75
The Role of Hippocampal Estradiol Receptor-α in a Perimenopausal Affective Disorders-Like Rat Model and Attenuating of Anxiety by Electroacupuncture. Evid Based Complement Alternat Med (2016) 0.75
Cognitive changes across the menopause transition: A longitudinal evaluation of the impact of age and ovarian status on spatial memory. Horm Behav (2016) 0.75
Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors. Front Neuroendocrinol (2016) 0.75
Protective Effect of 17β-Estradiol Upon Hippocampal Spine Density and Cognitive Function in an Animal Model of Vascular Dementia. Sci Rep (2017) 0.75
Estrogen deficiency is associated with hippocampal morphological remodeling of early postmenopausal mice. Oncotarget (2017) 0.75
Understanding the impact of breast cancer adjuvant endocrine therapy on cognitive function: a work in progress. Br J Cancer (2016) 0.75
17β-estradiol regulates the RNA-binding protein Nova1, which then regulates the alternative splicing of estrogen receptor β in the aging female rat brain. Neurobiol Aging (2017) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50
Estrogen therapy and coronary-artery calcification. N Engl J Med (2007) 8.70
National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA (2004) 7.68
Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA (2002) 6.72
Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med (2004) 6.42
The protective effects of estrogen on the cardiovascular system. N Engl J Med (1999) 6.25
Molecular and cellular basis of cardiovascular gender differences. Science (2005) 4.37
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28
Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial. Ann Intern Med (2010) 4.27
Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med (2006) 3.91
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA (2004) 3.85
Estrogen actions in the central nervous system. Endocr Rev (1999) 3.64
The right answer for the wrong question: consequences of type III error for public health research. Am J Public Health (1999) 3.62
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am J Epidemiol (2009) 3.33
Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause? Am J Epidemiol (2007) 2.85
Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) (2006) 2.77
Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women. Am J Med (2009) 2.64
Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci (2003) 2.40
Premature menopause or early menopause: long-term health consequences. Maturitas (2009) 2.33
Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA (2001) 2.32
KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric (2005) 2.32
Hormone therapy prescribing patterns in the United States. Obstet Gynecol (2004) 2.29
Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab (1998) 2.27
Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int (2008) 2.26
Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis. J Clin Oncol (2004) 2.24
27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med (2007) 2.18
Is early natural menopause a biologic marker of health and aging? Am J Public Health (1989) 2.16
Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA (1998) 2.14
HRT and the young at heart. N Engl J Med (2007) 2.07
Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology (1992) 2.05
Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology (1988) 1.99
Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J Neurosci (2006) 1.95
The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends Neurosci (2008) 1.74
Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab (1999) 1.67
The search for genes contributing to endometriosis risk. Hum Reprod Update (2008) 1.58
Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J Neurosci (2002) 1.50
Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J Comp Neurol (2003) 1.49
Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys. Cereb Cortex (2004) 1.48
Vasomotor symptoms and coronary artery calcium in postmenopausal women. Menopause (2010) 1.47
ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy. Obstet Gynecol (2008) 1.45
The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience (2000) 1.41
The association of hysterectomy and menopause: a prospective cohort study. BJOG (2005) 1.41
Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr Rev (2009) 1.33
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ (2010) 1.32
Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology (1999) 1.31
Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta (2006) 1.26
Effect of bilateral oophorectomy on women's long-term health. Womens Health (Lond Engl) (2009) 1.21
Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev (2008) 1.20
Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause (2006) 1.18
Sex steroids to maintain cognitive function in women after the menopause: a meta-analyses of treatment trials. Maturitas (2010) 1.17
Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging. Womens Health (Lond Engl) (2009) 1.16
Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Prog Brain Res (2010) 1.16
Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study. Dement Geriatr Cogn Disord (2010) 1.14
Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis. Neurodegener Dis (2010) 1.11
Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline. Horm Behav (1998) 1.09
Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Am J Epidemiol (2009) 1.08
The long-term effects of oophorectomy on cognitive and motor aging are age dependent. Neurodegener Dis (2008) 1.06
Estrogen regulates neprilysin activity in rat brain. Neurosci Lett (2004) 1.02
Neuroscience: it's all in the timing. Nature (2007) 1.02
Increases in luteinizing hormone are associated with declines in cognitive performance. Mol Cell Endocrinol (2007) 0.96
Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis. Ann N Y Acad Sci (2005) 0.92
Incidence of dementia in long-term hormone users. Am J Epidemiol (2008) 0.91
Postmenopausal estrogen therapy and Alzheimer disease: overall negative findings. Alzheimer Dis Assoc Disord (2006) 0.91
Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females. Eur J Neurol (2006) 0.89
Gonadotropins and cognition in older women. J Alzheimers Dis (2008) 0.87
The search for genetic variants predisposing women to endometriosis. Curr Opin Obstet Gynecol (2007) 0.87
EMAS position statement: Managing women with premature ovarian failure. Maturitas (2010) 0.86
Semantics, menopause-related terminology, and the STRAW reproductive aging staging system. Menopause (2001) 0.86
Estrogen Receptor 1 gene (ESR1) variants in Alzheimer's disease. Results of a meta-analysis. Aging Clin Exp Res (2007) 0.84
Use of estrogens for the prevention and treatment of Alzheimer's disease. Dement Geriatr Cogn Disord (2000) 0.84
Two approaches to etiology: the debate over smoking and lung cancer in the 1950s. Endeavour (2004) 0.83
The continuum of ovarian aging and clinicopathologies associated with the menopausal transition. Maturitas (2010) 0.80
Should surgical menopausal women be treated with estrogens to decrease the risk of dementia? Neurology (2007) 0.80
Reproductive hormones, cancers, and conditions in relation to a common genetic variant of luteinizing hormone. Hum Reprod (2000) 0.77
Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol (2011) 8.00
History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc (2012) 6.54
Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc (2012) 6.21
Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol (2012) 4.47
Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol (2006) 3.81
Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. Eur Heart J (2005) 2.45
Premature menopause or early menopause: long-term health consequences. Maturitas (2009) 2.33
Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int (2008) 2.26
Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause (2008) 1.92
Increased cardiovascular mortality after early bilateral oophorectomy. Menopause (2009) 1.89
Premature menopause or early menopause and risk of ischemic stroke. Menopause (2012) 1.84
Vulvovaginal atrophy. Mayo Clin Proc (2010) 1.81
Embedding concepts of sex and gender health differences into medical curricula. J Womens Health (Larchmt) (2013) 1.59
Novel use of Kaplan-Meier methods to explain age and gender differences in hypertension control rates. Hypertension (2008) 1.55
Caffeine and menopausal symptoms: what is the association? Menopause (2015) 1.43
Incidence, time trends, laterality, indications, and pathological findings of unilateral oophorectomy before menopause. Menopause (2014) 1.42
The trained observer better predicts daytime ABPM diastolic blood pressure in hypertensive patients than does an automated (Omron) device. Blood Press Monit (2006) 1.38
Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. JAMA Neurol (2013) 1.32
Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord (2010) 1.22
Chemical exposures and Parkinson's disease: a population-based case-control study. Mov Disord (2006) 1.20
Incretin effect potentiates beta-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study. Am J Physiol Endocrinol Metab (2006) 1.18
Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging. Womens Health (Lond Engl) (2009) 1.16
Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol (2013) 1.11
Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis. Neurodegener Dis (2010) 1.11
The long-term effects of oophorectomy on cognitive and motor aging are age dependent. Neurodegener Dis (2008) 1.06
Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. Arch Neurol (2007) 1.05
C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens (2005) 1.03
Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. Arch Gen Psychiatry (2007) 1.02
Hysterectomy, oophorectomy, estrogen, and the risk of dementia. Neurodegener Dis (2012) 1.01
Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: a population-based study. Epilepsy Res (2011) 1.00
Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease. Mov Disord (2007) 1.00
Comparison of usefulness of echocardiographic Doppler variables to left ventricular end-diastolic pressure in predicting future heart failure events. Am J Cardiol (2006) 0.99
Increased mortality for neurological and mental diseases following early bilateral oophorectomy. Neuroepidemiology (2009) 0.97
Recognition and management of nonrelaxing pelvic floor dysfunction. Mayo Clin Proc (2012) 0.96
Use of bioidentical compounded hormones for menopausal concerns: cross-sectional survey in an academic menopause center. J Womens Health (Larchmt) (2011) 0.96
The impact of observer and patient factors on the occurrence of digit preference for zero in blood pressure measurement in a hypertension specialty clinic: evidence for the need of continued observation. Am J Hypertens (2006) 0.95
Epilepsy-related mortality is low in children: a 30-year population-based study in Olmsted County, MN. Epilepsia (2012) 0.94
A single dose of neuron-binding human monoclonal antibody improves spontaneous activity in a murine model of demyelination. PLoS One (2011) 0.94
Predictors of patient comfort and adherence with less frequent cervical cancer screening. Qual Prim Care (2011) 0.94
Risk factors for Parkinson's disease may differ in men and women: an exploratory study. Horm Behav (2012) 0.94
Challenging and complex decisions in the management of the BRCA mutation carrier. J Womens Health (Larchmt) (2013) 0.89
Metabolic markers or conditions preceding Parkinson's disease: a case-control study. Mov Disord (2012) 0.86
The Mayo Clinic cohort study of personality and aging: design and sampling, reliability and validity of instruments, and baseline description. Neuroepidemiology (2006) 0.85
Completion of the human papillomavirus vaccination series lags in Somali adolescents. J Low Genit Tract Dis (2013) 0.85
Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause. Biol Sex Differ (2013) 0.83
Risk of glaucoma after early bilateral oophorectomy. Menopause (2014) 0.83
A population-based study of long-term outcomes of cryptogenic focal epilepsy in childhood: cryptogenic epilepsy is probably not symptomatic epilepsy. Epilepsia (2011) 0.83
Number of children and risk of Parkinson's disease. Mov Disord (2007) 0.82
Discarding the first of three nurse-auscultatory or oscillometric blood pressure measurements does not improve the association of office blood pressure with ABPM. Blood Press Monit (2010) 0.82
Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus. Mov Disord (2007) 0.80
Controversy of hormone treatment and cardiovascular function: need for strengthened collaborations between preclinical and clinical scientists. Curr Opin Investig Drugs (2003) 0.80
Reassessing hysterectomy. Minn Med (2012) 0.79
Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study. Neurology (2010) 0.77
Bioidentical compounded hormones: a pharmacokinetic evaluation in a randomized clinical trial. Maturitas (2013) 0.76
Hormonal contraception and migraine: clinical considerations. Curr Pain Headache Rep (2012) 0.76
The burden of pain with menopause. Menopause (2012) 0.75
Could estrogen protect younger menopausal women from stroke? Expert Rev Neurother (2012) 0.75
Bell's palsy preceding Parkinson's disease: a case-control study. Mov Disord (2009) 0.75
Clinical failure of botulinum toxin A in movement disorders. Parkinsonism Relat Disord (2011) 0.75
Outcomes in women age 40 years and older with cytologically benign endometrial cells. Am J Obstet Gynecol (2012) 0.75